Vertex Pharmaceuticals (VRTX) Cash & Current Investments (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Cash & Current Investments of $7.85 billion for Q2 2026, up 23.0% from $6.38 billion a year earlier and up 8.4% from the prior quarter.
Vertex Pharmaceuticals (VRTX) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals' Cash & Current Investments came in at $6.61 billion, up 8.0% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Cash & Current Investments was $6.12 billion in FY2024 (-45.5%), $11.22 billion in FY2023 (+4.1%), $10.78 billion in FY2022 (+43.2%) and $7.52 billion in FY2021 (+13.0%).
- The Q2 2026 figure stands as the highest quarterly Cash & Current Investments since Q1 2024.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with an average decline of 9.4% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2022, with growth of 43.2%; the weakest was Q2 2024, with a decline of 48.4%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $7.25 billion (Q1 2026), $6.61 billion (Q4 2025) and $6.29 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 20.76 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.14 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 9.92 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 4.97 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 11.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 7.85 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 11.07 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.85 Bn |
| Mar 31, 2026 | 7.25 Bn |
| Dec 31, 2025 | 6.61 Bn |
| Sep 30, 2025 | 6.29 Bn |
| Jun 30, 2025 | 6.38 Bn |
| Mar 31, 2025 | 6.20 Bn |
| Dec 31, 2024 | 6.12 Bn |
| Sep 30, 2024 | 6.52 Bn |
| Jun 30, 2024 | 5.80 Bn |
| Mar 31, 2024 | 10.17 Bn |
| Dec 31, 2023 | 11.22 Bn |
| Sep 30, 2023 | 11.93 Bn |
| Jun 30, 2023 | 11.24 Bn |
| Mar 31, 2023 | 10.41 Bn |
| Dec 31, 2022 | 10.78 Bn |
| Sep 30, 2022 | 9.77 Bn |
| Jun 30, 2022 | 9.25 Bn |
| Mar 31, 2022 | 8.24 Bn |
| Dec 31, 2021 | 7.52 Bn |
| Sep 30, 2021 | 6.96 Bn |
Vertex Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();